Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome

American Journal of Hematology

Volumn 71, Issue 1, 2002, Pages 11-14

  Li, Xiao Mei ^a,c   Wei, Ying Fei ^a   Hao, Hong Ling ^a   Hao, Yu Bin ^a   He, Li Shan ^b   Li, Jing Dong ^b   Mei, Bing ^a   Wang, Su Yun ^a   Wang, Chao ^a   Wang, Jun Xiang ^a   Zhu, Jun Zhen ^a   Liang, Jin Quan ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c NONE   (China)

Author keywords

Budd Chiari syndrome; Hyperhomocysteinemia; Methylenetetrahydrofolate reductase gene mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATIC VEIN THROMBOSIS; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; PREVALENCE; RISK; RISK FACTORS; THROMBOPHILIA;

EID: 0036712720     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10149     Document Type: Article

References (31)

1. The Buddi-Chiari syndrome revisited
2. Hepatic and portal vein thrombosis
3. Budd-Chiari syndrome attributed to protein C deficiency
4. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome
5. Budd-Chiari syndrome and factor V Leiden mutation
6. Budd-Chiari syndrome in a patient heterozygous for the G20210A mutation of the prothrombin gene
7. Hyperhomocysteinemia and venous thrombosis: A meta-analysis
8. Hyperhomocysteinemia: A risk factor for arterial and venous thrombosis
9. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
10. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
11. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease
12. Bignell reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:QS06)
13. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
14. The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis
15. High-performance liquid chromatographic method with fluorescence detection for the determination of total homocyst(e)ine in plasma
16. Prevalence of moderate hyperhomocysteinemia in patients with early onset venous and arterial thrombosis
17. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis
18. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
19. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study
20. Hyperhomocysteinemia: A risk factor for central retinal vein occlusion
21. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: More evidence from a case-control study
22. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
23. 12 concentrations and risk for early-onset coronary artery disease
24. Plasma homocyst(e)ine levels and graded risk for myocardial infarction: Findings in two populations at contrasting risk for coronary heart disease
25. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells
26. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
27. Homocysteine and hemostasis: Pathogenic mechanisms predisposing to thrombosis
28. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients
29. Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease
30. Homocysteine and thrombotic disease
31. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population